Capecitabine: Still a Standard Option in the Adjuvant Setting of Biliary Tract Cancer?. Issue 31 (1st November 2022)

Record Type:: Journal Article
Title:: Capecitabine: Still a Standard Option in the Adjuvant Setting of Biliary Tract Cancer?. Issue 31 (1st November 2022)
Main Title:: Capecitabine: Still a Standard Option in the Adjuvant Setting of Biliary Tract Cancer?
Authors:: Edeline, Julien
Malka, David
Abstract:
Is Part Of:: Journal of clinical oncology. Volume 40:Issue 31(2022)
Journal:: Journal of clinical oncology
Issue:: Volume 40:Issue 31(2022)
Issue Display:: Volume 40, Issue 31 (2022)
Year:: 2022
Volume:: 40
Issue:: 31
Issue Sort Value:: 2022-0040-0031-0000
Page Start:: 3667
Page End:: 3668
Publication Date:: 2022-11-01
Subjects:: Oncology -- Periodicals
Cancer -- Periodicals
Oncology
Medical Oncology
Cancérologie -- Périodiques
Cancer -- Périodiques
Cancérologie
Cancer
Oncology
Oncologia
Càncer
Periodicals
616.994
Journal URLs:: http://www.jco.org/ ↗
http://jco.ascopubs.org/ ↗
http://journals.lww.com/pages/default.aspx ↗
DOI:: 10.1200/JCO.22.01213 ↗
Languages:: English
ISSNs:: 0732-183X
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 24607.xml